Search

anti vegf header

Editorial Feature:

Anti-VEGF: The Next Generation

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Show Description +

How do you course-correct a suspected PCV case with a large PED when a decent start is followed by new hemorrhage? David Miller, MD, and guests Ehsan Rahimy, MD, and Esther Kim, MD, discuss a case that employed two next-generation therapies.

Posted: 11/10/2025

Keywords:

Neovascular Age-Related Macular Degeneration

•

Polypoidal choroidal vasculopathy, PCV

•

Pigment epithelial detachment, PED

•

Hemorrhage

Up Next

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

St<strike>ep</strike>upid Edits in a Neovascular AMD Patient

Stepupid Edits in a Neovascular AMD Patient

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Back to All Videos

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

How do you course-correct a suspected PCV case with a large PED when a decent start is followed by new hemorrhage? David Miller, MD, and guests Ehsan Rahimy, MD, and Esther Kim, MD, discuss a case that employed two next-generation therapies.

Posted: 11/10/2025

Keywords:

Neovascular Age-Related Macular Degeneration

•

Polypoidal choroidal vasculopathy, PCV

•

Pigment epithelial detachment, PED

•

Hemorrhage

Please log in to leave a comment.